Trial Profile
Non randomized trial to compare efficacy of tolvaptan and trichlormethiazide in adult congenital heart disease
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Jul 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Trichlormethiazide
- Indications Congenital heart defects; Heart failure
- Focus Therapeutic Use
- 01 Jul 2015 New trial record